These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17661270)

  • 1. [Effectiveness and safety of levetiracetam in patients with essential tremor: data from an open 11-week follow-up trial].
    Sanz-Cartagena P; Fossas P; Floriach-Robert M; Serra-Prat M; Cano A; Palomeras E
    Rev Neurol; 2007 Aug 1-15; 45(3):134-6. PubMed ID: 17661270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam is not effective for essential tremor.
    Elble RJ; Lyons KE; Pahwa R
    Clin Neuropharmacol; 2007; 30(6):350-6. PubMed ID: 18090460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot efficacy and tolerability: a randomized, placebo-controlled trial of levetiracetam for essential tremor.
    Handforth A; Martin FC
    Mov Disord; 2004 Oct; 19(10):1215-21. PubMed ID: 15390011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open-label pilot study of levetiracetam for essential tremor.
    Ondo WG; Jimenez JE; Vuong KD; Jankovic J
    Clin Neuropharmacol; 2004; 27(6):274-7. PubMed ID: 15613931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam for cerebellar tremor in multiple sclerosis: an open-label pilot tolerability and efficacy study.
    Striano P; Coppola A; Vacca G; Zara F; Brescia Morra V; Orefice G; Striano S
    J Neurol; 2006 Jun; 253(6):762-6. PubMed ID: 16683063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot, double-blind, placebo-controlled trial of pregabalin (Lyrica) in the treatment of essential tremor.
    Zesiewicz TA; Ward CL; Hauser RA; Salemi JL; Siraj S; Wilson MC; Sullivan KL
    Mov Disord; 2007 Aug; 22(11):1660-3. PubMed ID: 17580330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam for the treatment of essential tremor.
    Sullivan KL; Hauser RA; Zesiewicz TA
    Mov Disord; 2005 May; 20(5):640. PubMed ID: 15756652
    [No Abstract]   [Full Text] [Related]  

  • 8. A Novel Accelerometry Method to Perioperatively Quantify Essential Tremor Based on Fahn-Tolosa-Marin Criteria.
    Smid A; Pauwels RWJ; Elting JWJ; Everlo CSJ; van Dijk JMC; Oterdoom DLM; van Laar T; Tamasi K; van der Stouwe AMM; Drost G
    J Clin Med; 2023 Jun; 12(13):. PubMed ID: 37445270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor.
    Zesiewicz TA; Ward CL; Hauser RA; Sanchez-Ramos J; Staffetti JF; Sullivan KL
    Mov Disord; 2007 Jan; 22(2):279-82. PubMed ID: 17149715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pramipexole may be an effective treatment option in essential tremor.
    Herceg M; Nagy F; Pál E; Janszky J; Késmárky I; Komoly S; Kovács N
    Clin Neuropharmacol; 2012; 35(2):73-6. PubMed ID: 22318193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of levetiracetam on essential tremor.
    Bushara KO; Malik T; Exconde RE
    Neurology; 2005 Mar; 64(6):1078-80. PubMed ID: 15781835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregabalin (Lyrica) in the treatment of essential tremor.
    Zesiewicz TA; Ward CL; Hauser RA; Pease Campbell JA; Sullivan KL
    Mov Disord; 2007 Jan; 22(1):139-41. PubMed ID: 17089400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol.
    Morita S; Miwa H; Kondo T
    Parkinsonism Relat Disord; 2005 Mar; 11(2):101-3. PubMed ID: 15734668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term tremor therapy for Parkinson and essential tremor with sensor-guided botulinum toxin type A injections.
    Samotus O; Lee J; Jog M
    PLoS One; 2017; 12(6):e0178670. PubMed ID: 28586370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topiramate in essential tremor: findings from double-blind, placebo-controlled, crossover trials.
    Connor GS; Edwards K; Tarsy D
    Clin Neuropharmacol; 2008; 31(2):97-103. PubMed ID: 18382182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of levetiracetam in monotherapy in post-stroke seizures in the elderly population].
    García-Escrivá A; López-Hernández N
    Rev Neurol; 2007 Nov 1-15; 45(9):523-5. PubMed ID: 17979081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carisbamate in essential tremor: brief report of a proof of concept study.
    Elble RJ; Biondi DM; Ascher S; Wiegand F; Hulihan J
    Mov Disord; 2010 Apr; 25(5):634-8. PubMed ID: 20201005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease.
    Zesiewicz TA; Sullivan KL; Hauser RA; Sanchez-Ramos J
    Mov Disord; 2006 Nov; 21(11):1998-2001. PubMed ID: 16941461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of pregabalin in essential tremor: a randomized, double-blind, placebo-controlled, crossover trial.
    Ferrara JM; Kenney C; Davidson AL; Shinawi L; Kissel AM; Jankovic J
    J Neurol Sci; 2009 Oct; 285(1-2):195-7. PubMed ID: 19631949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levetiracetam versus carbamazepine in patients with late poststroke seizures: a multicenter prospective randomized open-label study (EpIC Project).
    Consoli D; Bosco D; Postorino P; Galati F; Plastino M; Perticoni GF; Ottonello GA; Passarella B; Ricci S; Neri G; Toni D;
    Cerebrovasc Dis; 2012; 34(4):282-9. PubMed ID: 23128439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.